Screener
Vera Therapeutics VERA Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Vera Therapeutics’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 5:25 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-077442
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Interest expense | (7,531) | (7,626) | (3,786) |
| Other (expense) income, net | (1,089) | 1,935 | 1,830 |
| Total other income, net | 15,859 | 15,023 | 6,023 |
| Loss before provision for income taxes | (299,614) | (152,147) | (95,989) |
| Provision for income taxes | (1) | (1) | (1) |
| Net loss | $(299,615) | $(152,148) | $(95,990) |
| Other comprehensive loss: | |||
| Change in fair value on marketable securities | 393 | 142 | 251 |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Vera Therapeutics's pre-tax income?
- Vera Therapeutics (VERA) reported pre-tax income of -$74.9M in Q4 2025.
- How has Vera Therapeutics's pre-tax income changed year-over-year?
- Vera Therapeutics's pre-tax income decreased by 96.9% year-over-year, from -$38.04M to -$74.9M.
- What is the long-term trend for Vera Therapeutics's pre-tax income?
- Over 4 years (2021 to 2025), Vera Therapeutics's pre-tax income has grown at a 74.1% compound annual growth rate (CAGR), from -$32.61M to -$299.61M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Vera Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude